Urticaria

Pavel Kolkhir(Fraunhofer Institute for Translational Medicine and Pharmacology), Marcus Maurer(Humboldt-Universität zu Berlin), Jonny Peter(University of Cape Town), Kanokvalai Kulthanan(Siriraj Hospital), Martin Metz(Humboldt-Universität zu Berlin), Ana M. Giménez‐Arnau(Universitat Autònoma de Barcelona)
Nature Reviews Disease Primers
September 15, 2022
10.1038/s41572-022-00389-z
Cited by 368

Related Papers

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
The <scp>EAACI</scp>/<scp>GA</scp><sup>2</sup><scp>LEN</scp>/<scp>EDF</scp>/<scp>WAO</scp> Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Allergy|2014|1.2k
Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
|New England Journal of Medicine|2013|1.1k
The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Dermatology Review|2015|429